GlassScriptPhysician profile
Rachel A Egler
NPI 1528148863
$883.42
in general payments reported to CMS, 2019-2025
18 companies · $89.05 in 2025
The $89.05 reported for 2025 was less than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $173 · 2021: $100 · 2022: $189 · 2023: $105 · 2024: $67.26 · 2025: $89.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $136.53 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.91 | 2019-2024 | |
| Genzyme Corporation | $84.89 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $81.43 | 2019-2023 | |
| Csl Behring | $79.26 | 2019-2025 | Hemgenix |
| Novo Nordisk INC | $66.90 | 2021-2025 | Alhemo |
| Takeda Pharmaceuticals U.S.A., INC. | $62.70 | 2023-2024 | Vonvendi |
| Jazz Pharmaceuticals INC. | $38.49 | 2019-2021 | |
| Adaptive Biotechnologies Corporation | $34.58 | 2020-2021 | |
| Global Blood Therapeutics, INC. | $34.50 | 2021-2022 | |
| Shire North American Group INC | $30.50 | 2019 | |
| Alexion Pharmaceuticals, INC. | $28.30 | 2019-2021 | |
| Pfizer INC. | $24.61 | 2025 | |
| Aurobindo Pharma USA, INC. | $18.47 | 2020 | |
| Bioverativ Therapeutics INC. | $18.01 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $16.40 | 2022 | |
| Chiesi USA, INC. | $15.29 | 2023 | Ferriprox |
| Grifols USA, LLC | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Egler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.